MacintyreS. Good intentions and received wisdom are not good enough: The need for controlled trials in public health. J Epidemiol Community Health, 2011; 65:564–567.
2.
JakobsenJC, GluudC. The necessity of randomized clinical trials. Br J Med Med Res, 2013; 3:1453–1468.
3.
KrzywinskiM, AltmanN. Significance, P values and t-tests. Nat Methods, 2013; 10:1041–1042.
4.
ButtonKS, IoannidisJP, MokryszC, et al.Confidence and precision increase with high statistical power. Nat Rev Neurosci, 2013; 14:585–586.
5.
IoannidisJP. Why most published research findings are false. PLoS Med, 2005; 2:e124.
6.
IoannidisJP. Why most discovered true associations are inflated. Epidemiology, 2008; 19:640–648.
7.
FanelliD, IoannidisJP. US studies may overestimate effect sizes in softer research. Proc Natl Acad Sci U S A, 2013; 110:15031–15036.
8.
LeonAC, DavisLL, KraemerHC. The role and interpretation of pilot studies in clinical research. J Psychiatr Res, 2011; 45:626–629.
9.
ArainM, CampbellMJ, CooperCL, et al.What is a pilot or feasibility study? A review of current practice and editorial policy. BMC Med Res Methodol, 2010; 10:67.
10.
KraemerHC, MintzJ, NodaA, et al.Caution regarding the use of pilot studies to guide power calculations for study proposals. Arch Gen Psychiatry, 2006; 63:484–489.
11.
BowenDJ, KreuterM, SpringB, et al.How we design feasibility studies. Am J Prev Med, 2009; 36:452–457.
12.
StevensJ, TaberDR, MurrayDM, et al.Advances and controversies in the design of obesity prevention trials. Obesity (Silver Spring), 2007; 15:2163–2170.
13.
MasicampoEJ, LalandeDR. A peculiar prevalence of p values just below .05. Q J Exp Psychol (Hove), 2012; 65:2271–2279.
14.
JohnsonVE. Revised standards for statistical evidence. Proc Natl Acad Sci U S A, 2013; 110:19313–19317.
